{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-26-002703","form_type":"8-K","ticker":"CNXU","cik":"0002066836","company_name":"Conexeu Sciences Inc.","filed_at":"2026-05-15T20:22:21+00:00","discovered_at":"2026-05-15T20:29:00.281284+00:00","generated_at":"2026-05-15T20:29:28.050666+00:00","sec_items":["3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Conexeu Sciences issues 4.34M shares on warrant exercise, raises ~$1.96M; amends bylaws to increase quorum","bullets":["Issued 4,342,648 common shares upon exercise of warrants for aggregate gross proceeds of ~$1,963,967.","Issued 4,342,648 Incentive Warrants exercisable at $2.30/share for 36 months as inducement.","Bylaws amended to increase stockholder meeting quorum from 5% to 33.3% to comply with Nasdaq Rule 5620(c).","Also issued 11,175 shares at $4.00 to a director for compensation on May 14, 2026.","Proceeds for working capital; 827,005 Program Warrants remain outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-26-002703","json":"https://secwatch.observer/filing/0001062993-26-002703.json","markdown":"https://secwatch.observer/filing/0001062993-26-002703.md","text":"https://secwatch.observer/filing/0001062993-26-002703.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2066836/000106299326002703/0001062993-26-002703-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2066836/000106299326002703/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T20:29:28.050666+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8807dedae86faf3e18356fe6baae6f327e93fcc1","claim":"Conexeu Sciences Inc.: Increased quorum requirement for stockholder meetings from one-twentieth to one-third of outstanding shares (effective 2026-05-11).","evidence_excerpt":"On May 11, 2026, the Board of Directors of the Company approved an amendment to the bylaws (the \" Bylaws \") of the Company in order to increase the quorum requirement for meetings of stockholders from one-twentieth (1/20) of the outstanding shares of the Company entitled to vote at any such meeting, represented in person or by proxy, to one-third (331⁄3%) of the outstanding shares of the Company entitled to vote, represented in person or by proxy.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/2066836/000106299326002703/0001062993-26-002703-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2026-05-11"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}